Navigation Links
Market Publishers Ltd and GenericsWeb Sign Partnership Agreement
Date:12/27/2010

LONDON, Dec. 27, 2010 /PRNewswire/ -- Market Publishers Ltd and GenericsWeb Pty Ltd signed partnership agreement for quality market research promotion on Internet. MarketPublishers.com is now authorized to distribute and sell GenericsWeb research reports.

Mrs. Alla Martin, Head of Partner Relations Department, mentioned in her comments on the agreement: "GenericsWeb is a highly professional company whose title speaks for itself – the company focuses on the pipeline products, new drugs developments, and extended patent information. We are sure that our clients will develop much interest in the products offered by GenericsWeb, among which there are regularly updated news and articles, business intelligence, industry links, product development services and e-newsletters."

In-demand market reports by GenericsWeb:

  • Repaglinide - Comprehensive Patent Search
  • Ribavirin - Comprehensive Patent Search
  • Riluzole - Comprehensive Patent Search
  • Rimonabant - Comprehensive Patent Search
  • Risedronic Acid - Comprehensive Patent Search
  • Risperidone - Comprehensive Patent Search
  • Ritonavir - Comprehensive Patent Search
  • Rituximab - Comprehensive Patent Search
  • Rivaroxaban - Comprehensive Patent Search
  • Rivastigmine - Comprehensive Patent Search

  • Each of the above mentioned reports is a regularly updated, professional patent search which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

    Each Patent Search features:

  • Comprehensive patent searching, covering the world's key territories;
  • Identifies patents covering molecule, formulation, process, use, combination and assay techniques;
  • Patent identification, categorisation and interpretation;
  • Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims;
  • Manual filtration of patents not relevant to generic development;
  • Updated on a monthly basis, including changes to patent families, statuses, and litigation;
  • Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers.

  • More details on GenericsWeb and their reports can be found at http://marketpublishers.com/members/genericsweb/info.htmlCONTACTS The Market Publishers, Ltd.Mrs. Alla MartinTel: +44 208 144 6009Fax: +44 207 900 3970ps@marketpublishers.comwww.marketpublishers.com
    '/>"/>

    SOURCE The Market Publishers Ltd
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
    2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
    3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
    4. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
    5. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
    6. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
    7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
    8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
    9. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
    10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
    11. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
    (Date:6/24/2016)... , June 24, 2016  Global Blood Therapeutics, ... company developing novel therapeutics for the treatment of ... announced the closing of its previously announced underwritten ... at the public offering price of $18.75 per ... were offered by GBT. GBT estimates net proceeds ...
    (Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
    Breaking Medicine Technology:
    (Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
    (Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
    (Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
    (Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
    (Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
    Breaking Medicine News(10 mins):